glp-1 drug shortages The shortage is over. What's next for the compounders? Medical student and researcher Ashwin

In the Phase 2 obesity data the weight curve was still trending downward at 48 weeks, so a genuine plateau at a tolerated maintenance dose may simply reflect the body settling toward a new set point rather than the protocol failing

What are the benefits of GLP-1 drugs

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

Endothelial GLP-1 (glucagon-like peptide-1) receptor mediates cardiovascular protection by liraglutide in mice with experimental arterial hypertension

This study followed the PRISMA (preferred reporting items for systematic reviews and meta-analyses) 2020 and extension statement for network meta-analyses (PRISMA-NMA)

By tracking your weight trends, symptoms, and labs, your clinician can see whats working, troubleshoot plateaus, and provide strategies to prevent rebound weight gain